Cases & Deals

Celgene files Hatch-Waxman suit against IntelliPharmaCeutics over Focalin XR® patent

Clients Celgene Corporation

Jones Day represented Celgene Corporation in a Hatch-Waxman patent litigation concerning a generic version of ADHD drug Focalin XR®.

Celgene Corporation, et al. v. IntelliPharmaCeutics Corp., Case No. 3-07-cv-04854 (D.N.J. 2007) (Judge Wolfson)